Strategic learning and evaluation are critical tools for cross-sector collaboration. In the latest FSG blog, we share lessons from our work with Partnering4Change (P4C)—a global partnership between the International Committee of the Red Cross (ICRC), the Danish Red Cross, and Novo Nordisk—to tackle the growing issue of non-communicable diseases (NCDs) in humanitarian crises.
By Chavanne Hanson, Deputy Head of Global Public Affairs
Blog
Today, the United Nations (UN) hosts a highly anticipated meeting to discuss progress and next steps on fighting chronic diseases like cancer, diabetes and heart disease – otherwise known as non-communicable diseases, or NCDs.
We’re keen to play our part, and indeed both the UN and World Health Organization (WHO) recently called upon food and beverage companies like Nestlé to engage in the battle against such diseases.
WHO Director-General Dr. Tedros wrote: "We must use whatever partnerships are open to us, in whatever way we can, to achieve our goals… it’s the only way."
Submit a Solvable Problem to be considered for PYXERA Global's 2018 Global Engagement Forum: Live
Press Release
WASHINGTON, January 11, 2018 /3BL Media/ - Do you know of a solvable problem within the United Nations' Global Goals that could be solved with the right resources, network, and collaboration?
Poor patients in Punjab will have access to high-quality medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access
Punjab government will make medicines available free of charge through public sector hospitals from early 2018 onward
Pakistan is among the countries most affected by chronic diseases; more than half of its population lives in the Punjab province
Article
Poor patients in Punjab will have access to high-quality medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access
Punjab government will make medicines available free of charge through public sector hospitals from early 2018 onward
Pakistan is among the countries most affected by chronic diseases; more than half of its population lives in the Punjab province
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Summary:
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Cameroon Baptist Convention Health Services have started distributing medicines in selected parts of the country; capacity-building activities to kick off this month
Cameroon becomes the sixth country to launch Novartis Access
Press Release
Novartis reaches agreement with Cameroon to supply medicines against chronic diseases for the poorest populations
Cameroon Baptist Convention Health Services have started distributing medicines in selected parts of the country; capacity-building activities to kick off this month
Cameroon becomes the sixth country to launch Novartis Access
Alvine strives to get affordable drugs for hypertension in Cameroon
Article
This month like the previous ones, Alvine Nyintché is visiting the Etoug-Ebe Baptist Hospital in Yaounde. Aged 50, Alvine has been diagnosed with high blood pressure seven years ago.
“Most Cameroonians do not have medical insurance. Today, I pay 800 francs CFA every month for my hypertension treatment (about USD 1.5), whereas just a few months back, it cost me 5000 CFA francs. I am a single mother. My two daughters are unemployed and we have to pay rent,” says Alvine, who lives in Briqueterie, one of the largest slums of the Cameroonian capital.
PYXERA Global is Hosting Fall Virtual Event Series on the Youth Skills Gap, Post-Harvest Loss, and Treatable and Preventable NCDs
Press Release
WASHINGTON, July 26, 2017 /3BL Media/ -The time is now to engage partners, begin collaborations, scale solutions, and make progress on solvable problems such as reducing post-harvest loss, bridging youth skills gap and increasing employability, and treating and preventing non-communicable diseases (NCDs). PYXERA Global will host a #GEFlive fall virtual event series on those three solvable problems, starting in September.
Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Article
Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
Blog
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
